InsidersTradesSigma
Track the 辰欣药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 辰欣药业 has published 3 public disclosures. Market capitalisation: €6.3bn. The latest transaction was reported on 20 October 2022 (Purchase). Among the most active insiders: 杜振新. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
辰欣药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and manufacturing of innovative medicines.